Connect with us

Business Partnerships

PharmaCielo and Veterinary CBD Company Laboratorios Adler Partner to for Latin America Expansion

Published

on

PharmaCielo and Veterinary CBD Company Laboratorios Adler Partner to for Latin America Expansion

PharmaCielo Ltd., a cannabis company based in Canada, recently announced that it will be partnering with Laboratorios Adler, a Uruguay-based company. Through the partnership, the former will supply the latter with CBD isolate, bulk CBD extracts, and bottled oils for veterinary use.

According to the press release announcing the partnership, the agreement will run for four years, with options for renewal. It is the first collaboration between the brands.

David Attard, the CEO of PharmaCielo Ltd. shared in the press release,

“This exciting entry into the animal health marketplace through the agreement with Adler is an example of PharmaCielo executing on its strategic objectives to supply both bulk oil and proprietary products to customers using established large chain distributors.”

He continued.

“Including Creso Pharma's animal health products also demonstrates both the mutual strategic value of our Creso acquisition proposal, which will be fully realized upon completion of the transaction, and the value of branded, fully manufactured product to provide enhanced margin opportunity. We are thrilled about the potential this agreement brings to all parties, and we look forward to working with our Latin American and European partners.”

Laboratorios Adler serves a wide range of customers, from pet shop to clinics and wholesale distributors. The products provided by PharmaCielo will be able address trauma pain, and cancer-related pain, among domestic and large animals.

Adriana Adler, the CFO of Laboratories Adler, shared in the press release,

“We are seeing increased demand for CBD-based veterinary products across all our markets as customers look for natural solutions to address pain, stress and a variety of other ailments in both domestic and large animals.”

She added,

“Partnering with PharmaCielo gives us an incredible advantage in this rapidly developing category. Creso Pharma's anibidiol® line of products, targeting stress, behavioral problems and chronic pain, along with PharmaCielo's CBD isolate, among the purest and highest quality we've seen, make a great addition to our product portfolio.”

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.